// App-Quantinova.ai

BSH19‐EP‐037 : Incidence and grade of non‐melanoma skin cancers in patients of long‐term Bruton's Tyrosine Kinase inhibitor therapy: a single centre study

Researchers

Presenter

  • J. Vaz

Principal Investigators

  • R. McCulloch

  • N. Crosbie

  • S. Rule

Medical Centers

  • Peninsula Medical School, Plymouth University

  • Rheumatology, Derriford Hospital, Plymouth, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Waldenstrom’s macroglobulinemia

  • Diffuse large B-cell lymphoma

  • Chronic Lymphocytic Leukemia

  • Squamous cell carcinoma

  • Basal cell carcinoma

  • Mantle cell lymphoma

  • Hodgkin's Lymphoma

  • B cell lymphomas

  • Non‐Hodgkin Lymphoma

  • Solid malignancies

  • Melanoma

  • Lymphomas

Biomarkers

  • Bruton tyrosine kinase

  • Serpin B3

Drug/Treatment

  • ACP-196

  • Tirabrutinib

  • Ibrutinib

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Double Blind/Blinded

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved